RE: Re rate14 May 2023 11:51
My understanding on the CBR situation, happy to be corrected if factually wrong:
Hemogenyx filed a provisional patent application March last year: https://www.lse.co.uk/rns/HEMO/cbr-update-fywrltwvmef20hc.html
One year later, so March this year or earlier they would have filed a full patent application which extends this IP protection to 20 years, had they failed to do this it would have been market sensitive and required an RNS as it would remove any protection for CBR/ indicated it did not work. Full application is anticipated and expected as part of normal business operations and therefore not market sensitive.
So what is this talk about "September"?
The applicant companies have a grace period in their Patent application when they dont have to tell everyone HOW their technology works, they can keep the secret sauce ingredients secret. They still OWN the right to exclusively use that secret sauce but it just becomes much easier for competition to see HOW you made your sauce, look for gaps or loop holes and basically turns up the heat.
It can be a good thing as if the patent application is very solid and strong and covers every permutation of protein then the competition may decide its so valuable the only option is to licence from Hemogenyx or move to acquire Hemogenyx as a whole. Or competition may find small tweaks enough to make their offering different enough to skirt the patent.
Bottom line is, come October, even if there is zero updates on Hemogenyx on CBR, they will not lose any protection, just the shroud of secrecy which has allowed them to progress without anyone biting at their heels.
As for what updates are actually expected? I have lost track, I THINK its being tested with multiple tracks? If memory serves there is a governmental institution testing one CBR on a family of viruses including Marburg, Ebola etc. There is in vivo testing on Covid-19 and strains which was some Lvl 3 facility, cant remember who if the even said? And there was testing against a solid cancer? Presume this one was in house?
Really not sure, I am confident that CBR will be and is huge, and I agree an update is likely very soon, IMO BEFORE the CAR-T IND is accepted, but god only knows what that update will be, hopefully in Vivo results on Covid-19 or the Ebola variant CBR.